Safety and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes: An Integrated Analysis of 4328 Patients

被引：0
|
作者：
Macconell, Leigh
Gurney, Kate
Malloy, Jaret
Zhang, H.
Zhou, Ming
Chen, Steve
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2372-PO
引用
收藏
页码：A598 / A598
页数：1
相关论文
共 50 条
  • [41] Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
    Inaishi, Jun
    Saisho, Yoshifumi
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2022, 14 : 19 - 26
  • [42] Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus
    Kothare, Prajakti A.
    Linnebjerg, Helle
    Isaka, Yoshitaka
    Uenaka, Kazunori
    Yamamura, Ayuko
    Yeo, Kwee Poo
    de la Pena, Amparo
    Teng, Choo Hua
    Mace, Kenneth
    Fineman, Mark
    Shigeta, Hirofumi
    Sakata, Yukikuni
    Irie, Shin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (12): : 1389 - 1399
  • [43] Intranasal administration of exenatide in patients with type 2 diabetes: pharmacokinetics, pharmacodynamics, safety and tolerability
    Blase, E.
    Deng, W.
    Walsh, B.
    Fineman, M.
    Rhodes, C.
    DIABETOLOGIA, 2008, 51 : S346 - S346
  • [44] Comparison of Safety with Continuous (Exenatide Once Weekly) or Intermittent (Exenatide Twice Daily) GLP-1 Receptor Agonism in Patients with Type 2 Diabetes
    Moretto, Thomas
    Ridge, Terry
    Macconell, Leigh
    Pencek, Rich
    Han, Jenny
    Schulteis, Christine
    Porter, Lisa
    DIABETES, 2011, 60 : A285 - A285
  • [45] Comparison of safety with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes
    Ridge, T.
    Moretto, T.
    MacConell, L.
    Pencek, R.
    Han, J.
    Schulteis, C.
    Porter, L.
    DIABETOLOGIA, 2011, 54 : S325 - S325
  • [46] Intranasal administration of exenatide in patients with type 2 diabetes: Pharmacokinetics, pharmacodynamics, safety, and tolerability
    Blase, Erich
    Deng, Wei
    Walsh, Brandon
    Fine-Man, Mark
    Rhodes, Christopher
    DIABETES, 2008, 57 : A58 - A58
  • [47] Safety and Tolerability of Exenatide Once Weekly Pooled Summary of 1095 Patients from DURATION-1, 2, and 3
    Bruce, Simon
    Han, Jenny
    Brown, Carl
    Nicewarner, Dawn
    Ferguson, Jeff
    Lee, Dana
    Boies, Laura
    DIABETES, 2010, 59 : A16 - A17
  • [48] A NETWORK META ANALYSIS TO COMPARE GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH EXENATIDE ONCE WEEKLY OR LIRAGLUTIDE
    Scott, D.
    Boye, K. S.
    Timlin, L.
    Best, J. H.
    Clark, J.
    VALUE IN HEALTH, 2011, 14 (07) : A472 - A473
  • [49] Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes
    Steven P. Marso
    Elise Hardy
    Jenny Han
    Hui Wang
    Robert J. Chilton
    Diabetes Therapy, 2018, 9 : 551 - 564
  • [50] Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes
    Marso, Steven P.
    Hardy, Elise
    Han, Jenny
    Wang, Hui
    Chilton, Robert J.
    DIABETES THERAPY, 2018, 9 (02) : 551 - 564
12345